RETRACTED: Antiproliferative Activity of Triterpene Glycoside Nutrient from Monk Fruit in Colorectal Cancer and Throat Cancer (Nutrients, (2016), 8, 6, (360), 10.3390/nu8060360);Antiproliferative activity of triterpene glycoside nutrient from monk fruit in colorectal cancer and throat cancer

Nutrients

Volumn 8, Issue 6, 2016, Pages

  Liu, Can ^a,b,c   Dai, Longhai ^b   Liu, Yueping ^a,c   Rong, Long ^d   Dou, Dequan ^a   Sun, Yuanxia ^b   Ma, Lanqing ^a,c  

^a BEIJING UNIVERSITY OF AGRICULTURE   (China)

^b Tianjin Airport Economic Area   (China)

^c Beijing Collaborative Innovation Center for Eco Environmental Improvement with Forestry and Fruit Trees   (China)

^d BEIHANG UNIVERSITY   (China)

Author keywords

Colorectal cancer; Mogroside IVe; Monk fruit; Throat cancer

Indexed keywords

MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MOGROSIDE IVE; PLANT EXTRACT; PROTEIN P53; TRITERPENE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; GELATINASE B; GLYCOSIDE; MMP9 PROTEIN, HUMAN; PLANT MEDICINAL PRODUCT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PREVENTION; CELL PROLIFERATION; CELL VIABILITY; CHINESE HERB; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; FRUIT; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MOUSE; MTT ASSAY; NONHUMAN; PHARYNX CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COLORECTAL NEOPLASMS; CUCURBITACEAE; DRUG EFFECTS; DRUG SCREENING; GENETICS; HT-29 CELL LINE; MALE; METABOLISM; PHARYNGEAL NEOPLASMS; PHOSPHORYLATION; TUMOR CELL LINE; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CUCURBITACEAE; DOWN-REGULATION; FRUIT; GLYCOSIDES; HT29 CELLS; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; PHARYNGEAL NEOPLASMS; PHOSPHORYLATION; PHYTOCHEMICALS; PLANT EXTRACTS; TRITERPENES; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84973861249     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu16172846     Document Type: Erratum

References (39)

1. Newman, D.J, Cragg, G.M, Snader, K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 2003, 66, 1022-1037. [CrossRef] [PubMed]
2. Agbarya, A, Ruimi, N, Epelbaum, R, Ben-Arye, E, Mahajna, J. Natural products as potential cancer therapy enhancers: A preclinical update. SAGE Open Med. 2014, 2. [CrossRef] [PubMed]
3. Nobili, S, Lippi, D, Witort, E, Donnini, M, Bausi, L, Mini, E, Capaccioli, S. Natural compounds for cancer treatment and prevention. Pharmacol. Res. 2009, 59, 365-378. [CrossRef] [PubMed]
4. Mukherjee, A.K, Basu, S, Sarkar, N, Ghosh, A.C. Advances in cancer therapy with plant based natural products. Curr. Med. Chem. 2001, 8, 1467-1486. [CrossRef] [PubMed]
5. Butler, M.S. The role of natural product chemistry in drug discovery. J. Nat. Prod. 2004, 67, 2141-2153. [CrossRef] [PubMed]
6. Li, X, Lopetcharat, K, Drake, M. Parents’ and children’s acceptance of skim chocolate milks sweetened by monk fruit and stevia leaf extracts. J. Food Sci. 2015, 80, S1083-S1092. [CrossRef] [PubMed]
7. Chun, L.I, Lin, L.M, Feng, S.; Wang, Z.M, Huo, H.R, Li, D, Jiang, T.L. Chemistry and pharmacology of Siraitia grosvenorii: A review. Chin. J. Nat. Med. 2014, 12, 89-102.
8. Kasai, R, Nie, R.L, Nashi, K, Ohtani, K, Zhou, J, Tao, G.D, Tanaka, O. Sweet cucurbitane glycosides from fruits of Siraitia siamensis (chi-zi luo-han-guo), a Chinese folk medicine. Agric. Biol. Chem. 1989, 53, 3347-3349. [CrossRef]
9. Suzuki, Y.A, Tomoda, M, Murata, Y, Inui, H, Sugiura, M, Nakano, Y. Antidiabetic effect of long-term supplementation with Siraitia grosvenori on the spontaneously diabetic Goto-Kakizaki rat. Br. J. Nutr. 2007, 97, 770-775. [CrossRef] [PubMed]
10. Matsumoto, K, Kasai, R, Ohtani, K, Tanaka, O. Minor cucurbitane-glycosides from fruits of Siraitia grosvenori (Cucurbitaceae). Chem. Pharm. Bull. 1990, 38, 2030-2032. [CrossRef]
11. Center, M.M, Jemal, A.; Ward, E. International trends in colorectal cancer incidence rates. Cancer Epidemiol. Biomark. Prev. 2009, 18, 1688-1694. [CrossRef] [PubMed]
12. Meijer van Putten, J.B. Mouth and throat cancer; new developments. Ned. Tijdschr. Tandheelkd. 1996, 103, 31-32. [PubMed]
13. Careaga, V, Bueno, C.C, Alche, L, Maier, M. Antiproliferative, cytotoxic and hemolytic activities of a triterpene glycoside from Psolus patagonicus and its desulfated analog. Chemotherapy 2009, 55, 60-68. [CrossRef] [PubMed]
14. Dyshlovoy, S.A, Menchinskaya, E.S, Venz, S, Rast, S, Amann, K, Hauschild, J, Otte, K, Kalinin, V.I, Silchenko, A.S, Avilov, S.A, et al. The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer. Int. J. Cancer 2015, 32, 1601-1618.
15. Qin, Z, Yong, X, Wang, J.F, Li, H, Long, T.T, Li, Z, Wang, Y.M, Dong, P, Xue, C.H. In vitro and in vivo anti-tumour activities of echinoside A and ds-echinoside A from Pearsonothuria graeffei. J. Sci. Food Agric. 2012, 92, 965-974.
16. Dai, L, Liu, C, Zhu, Y, Zhang, J, Men, Y, Zeng, Y, Sun, Y. Functional characterization of cucurbitadienol synthase and triterpene glycosyltransferase involved in biosynthesis of mogrosides from Siraitia grosvenorii. Plant Cell Physiol. 2015, 56, 1172-1182. [CrossRef] [PubMed]
17. Hohmann, A.W, Faulkner, P. Monoclonal antibodies to baculovirus structural proteins: determination of specificities byWestern blot analysis. Virology 1983, 125, 432-444. [CrossRef]
18. Shacter, E.; Williams, J.A, Lim, M, Levine, R.L. Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Radic. Biol. Med. 1994, 17, 429-437. [CrossRef]
19. Park, H.Y, Kim, J.H, Park, C.K. Activation of autophagy induces retinal ganglion cell death in a chronic hypertensive glaucoma model. Cell Death Dis. 2012, 3. [CrossRef] [PubMed]
20. Susini, L, Besse, S, Duflaut, D, Lespagnol, A, Beekman, C, Fiucci, G, Atkinson, A.R, Busso, D, Poussin, P, Marine, J.C, et al. TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ. 2008, 15, 1211-1220. [CrossRef] [PubMed]
21. Popovic, V, Zivkovic, J, Davidovic, S, Stevanovic, M, Stojkovic, D. Mycotherapy of Cancer: An update on cytotoxic and antitumor activities of mushrooms, bioactive principles and molecular mechanisms of their action. Curr. Top Med. Chem. 2013, 13, 2791-2806. [CrossRef] [PubMed]
22. Zhou, Y, Feng, X, Liu, Y.L, Ye, S.C, Wang, H, Tan, W.K, Tian, T, Qiu, Y.M, Luo, H.S. Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways. PLoS ONE 2013, 8. [CrossRef] [PubMed]
23. Moulik, S, Sen, T, Dutta, A, Banerji, A. Phosphatidylinositol 3-Kinase and NF-kappaB Involved in Epidermal Growth Factor-Induced Matrix Metalloproteinase-9 Expression. J. Cancer Mol. 2008, 4, 55-60.
24. Giono, L.E, Manfredi, J.J. The p53 tumor suppressor participates in multiple cell cycle checkpoints. J. Cell Physiol. 2006, 209, 13-20. [CrossRef] [PubMed]
25. Merchant, A.K, Loney, T.L, Maybaum, J. Expression of wild-type p53 stimulates an increase in both Bax and Bcl-xL protein content in HT29 cells. Oncogene 1996, 13, 2631-2637. [PubMed]
26. Reyes-Zurita, F.J, Pachón-Peña, G, Lizárraga, D, Rufino-Palomares, E.E, Cascante, M, Lupiáñez, J.A. The natural triterpenemaslinic acid induces apoptosis in HT29 colon cancer cells by a JNK-p53-dependent mechanism. BMC Cancer 2011, 11. [CrossRef] [PubMed]
27. Corbiere, C, Liagre, B, Terro, F, Beneytout, J.-L. Induction of antiproliferative effect by diosgenin through activation of p53, release of apoptosis-inducing factor (AIF) and modulation of caspase-3 activity in different human cancer cells. Cell Res. 2004, 14, 188-196. [CrossRef] [PubMed]
28. Kenny, H.A, Swayamjot, K, Coussens, L.M, Ernst, L. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J. Clin. Invest. 2008, 118, 1367-1379. [CrossRef] [PubMed]
29. Van Zijl, F.V, Krupitza, G, Mikulits, W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat. Res. Rev. Mutat. 2011, 728, 23-34. [CrossRef] [PubMed]
30. Bogenrieder, T, Herlyn, M. Axis of evil: Molecular mechanism of cancer metastasis. Oncogene 2003, 22, 6524-6536. [CrossRef] [PubMed]
31. Leung, S.Y, Chen, X, Chu, K.M, Yuen, S.T, Mathy, J, Ji, J, Chan, A.S.Y, Li, R, Law, S, Troyanskaya, O.G, et al. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc. Natl. Acad. Sci. USA 2003, 99, 16203-16208. [CrossRef] [PubMed]
32. Maheswaran, S, Haber, D.A. Circulating tumor cells: A window into cancer biology and metastasis. Curr. Opin. Genet. Dev. 2010, 20, 96-99. [CrossRef] [PubMed]
33. Scott, V, Weinberg, R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147, 275-292.
34. Abrassart, S, Peter, R, Hoffmeyer, P. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo. Fundam. Clin. Pharmacol. 2013, 27, 557-569.
35. Li, R, Pan, Y, He, B, Xu, Y, Gao, T, Song, G, Sun, H, Deng, Q, Wang, S. Downregulation of CD147 expression by RNA interference inhibits HT29 cell proliferation, invasion and tumorigenicity in vitro and in vivo. Int. J. Oncol. 2013, 43, 1885-1894. [PubMed]
36. Xie, Z, Singh, M, Singh, K. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1β. J. Biol. Chem. 2004, 279, 39513-39519. [CrossRef] [PubMed]
37. Padmaja, K, Kasyapa, C.S, Lesleyann, H, Cowell, J.K. LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway. J. Biol. Chem. 2004, 279, 23151-23157.
38. Moshal, K, Sen, U.N, Henderson, B, Steed, M, Ovechkin, A, Tyagi, S. Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway. Am. J. Physiol. Cell Physiol. 2006, 290, C883-C891. [CrossRef] [PubMed]
39. Sun, D.K, Yang, S.I, Kim, H.C, Chan, Y.S, Ko, K.H. Inhibition of GSK-3β mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-κB in rat primary astrocyte. Brain Res. 2007, 1186, 12-20. [CrossRef] [PubMed]